Traditional neuronal culture methods lack reproducibility and are difficult to quantify, which hinders key data generation in research and development. Learn how Molecular Devices worked together with Ananda Devices to build standardized ways to generate reproducible, multiparametric data using the NeuroHTS™ platform and the 7-factor neuronal morphological analysis.
Takeaways include:
Listen in as we share how to get the most out of the enormous amount of data extracted from these experiments.
Key takeaways include:
The need to reduce drug attrition rates and the use of animal experimentation has led to the development of more complex in vitro models such as organoids. While organoids hold great potential for drug toxicity and efficacy assessment, their complexity introduces challenges that can hinder their wider use in existing drug development workflows.
Join the experts as they discuss how to standardize and optimize your 3D cultures to fully automate your organoid workflows and deliver robust, reproducible results.
Key takeaways include:
There is a growing need in cell-based assays for drug discovery and disease modeling to closely represent biologically relevant microenvironments. This has led to increased interest in three-dimensional (3D) models for assay development and phenotypic screening as they better represent the complexity of human tissue. However, reliability and scalability challenges associated with 3D model development impacts its widespread adoption.
3D organoids are becoming popular in drug discovery and disease modeling as they better represent biologically relevant microenvironments. However, the protocols for organoid assays are complex and often require labor-intensive monitoring by highly trained specialists. In addition, there is a lack of clarity about automation’s contribution to increasing assay throughput, scalability, and workflow reliability, while still reducing overall cost.
Key takeaways include: